Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
复制标题
DOI:
10.1021/mp300686g
复制
发表时间:
2013-08
影响因子:
4.9
通讯作者:
Jinhui Wu;Chenchen Song;Chenxiao Jiang;Xin Shen;Qian Qiao;Yiqiao Hu
中科院分区:
文献类型:
--
作者:
Jinhui Wu;Chenchen Song;Chenxiao Jiang;Xin Shen;Qian Qiao;Yiqiao Hu
Over recent years, cell surface nucleolin as an anticancer target has attracted many researchers' attentions. To improve the antitumor efficacy, we developed a nucleolin targeted protein nanoparticle (NTPN) delivery system in which human serum albumin (HSA) was used as drug carrier and a DNA aptamer named AS1411, which had high affinity to nucleolin, was used as a bullet. The HSA nanoparticles (NPs-PTX) were fabricated by a novel self-assembly method and then modified with AS1411 (Apt-NPs-PTX). The resulted Apt-NPs-PTX were spherical. Compared with NPs-PTX, the uptake of Apt-NPs-PTX displayed a significant increase in MCF-7 cells while there was a decrease in nontumor cell lines such as MCF-10A and 3T3 cells. In a cytotoxic study, Apt-NPs-PTX displayed an enhanced cytotoxicity in MCF-7 tumor cells while there was almost no cytotoxicity in MCF-10A cells. Endostatin, a nucleolin inhibitor, could significantly decrease the internalization of Apt-NPs-PTX, suggesting nucleolin mediates the transmembrane process of Apt-NPs-PTX. Therefore, the AS1411 modified NTPN delivery system might be a promising targeted drug delivery system.